+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Antagonist properties of a phosphono isoxazole amino acid at glutamate R1-4 (R,S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid receptor subtypes



Antagonist properties of a phosphono isoxazole amino acid at glutamate R1-4 (R,S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid receptor subtypes



Molecular Pharmacology 53(3): 590-596



The activity of the (R, S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA) receptor antagonist, (R,S) -2-amino-3-[5-tert-butyl-3-(phosphonomethoxy)-4-isoxazolyl] propionic acid (ATPO), at recombinant ionotropic glutamate receptors (GluRs) was evaluated using electrophysiological techniques. Responses at homo- or heterooligomeric AMPA-preferring GluRs expressed in human embryonic kidney (HEK) 293 cells (GluR1-flip) or Xenopus laevis oocytes (GluR1-4-flop or GluR1-flop + GluR2) were potently inhibited by ATPO with apparent dissociation constants (Kb values) ranging from 3.9 to 26 microM. A Schild analysis for kainate (KA)-activated GluR1 receptors showed ATPO to have a KB of 8.2 microM and a slope of unity, indicating competitive inhibition. The antagonism by ATPO at GluR1 was of similar magnitude at holding potentials between -100 mV and +20 mV. In contrast, ATPO (<300 microM), does not inhibit responses to kainate at homomeric GluR6 or heterooligomeric GluR6/KA2 expressed in HEK 293 cells but activated GluR5 and GluR5/KA2 expressed in X. laevis oocytes. ATPO produced <15% inhibition at the maximal concentration (300 microM) of current responses through NR1A + NR2B receptors expressed in X. laevis oocytes. Thus, ATPO shows a unique pharmacological profile, being an antagonist at GluR1-4 and a weak partial agonist at GluR5 and GluR5/KA2.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 068705450

Download citation: RISBibTeXText

PMID: 9495827

DOI: 10.1124/mol.53.3.590


Related references

Antagonist Properties of a Phosphono Isoxazole Amino Acid at Glutamate R14 ( R,S )-2-Amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic Acid Receptor Subtypes. Molecular Pharmacology 53(3): 590-596, 1998

Antagonist properties of a phosphono isoxazole amino acid at glutamate R1-4 -2-amino-3- propionic acid receptor subtypes. Molecular Pharmacology 53(3): 590-596, 1998

Structural analogs of ibotenic acid syntheses of 4 methyl homo ibotenic acid and r s alpha amino 3 hydroxy 5 methyl isoxazole 4 propionic acid including the crystal structure of r s alpha amino 3 hydroxy 5 methyl isoxazole 4 propionic acid mono hydrate. Acta Chemica Scandinavica Series B Organic Chemistry & Biochemistry 34(4): 235-240, 1980

The excitation of frog motoneurones in vitro by the glutamate analogue, DI-alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA), and the effect of amino acid antagonists. Neuroscience Letters 55(1): 77-82, 1985

Excitation of frog motoneurons in vitro by the glutamate analog d l alpha amino 3 hydroxy 5 methyl 4 isoxazole propionic acid a pharmacological study using amino acid antagonists. Journal of Physiology (Cambridge) 360: 65P, 1985

Studies on an (S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA) receptor antagonist IKM-159: asymmetric synthesis, neuroactivity, and structural characterization. Journal of Medicinal Chemistry 56(6): 2283-2293, 2013

Effect of YM90K, an alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid/kainate receptor antagonist on ischaemic rat cerebral lesions. Japanese Journal of Pharmacology 67(Suppl. 1): 276P, 1995

Lateral hypothalamic injections of glutamate, kainic acid, D,L-alpha-amino-3-hydroxy-5-methyl-isoxazole propionic acid or N-methyl-D-aspartic acid rapidly elicit intense transient eating in rats. Brain Research 613(1): 88-95, 1993

Ligand recognition in glutamate receptors: insights from mutagenesis of the soluble -amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (Ampa)-binding domain of glutamate receptor type D (GluR-D). Biochemical Society Transactions 25(3): 835-838, 1997

Ligand recognition in glutamate receptors: insights from mutagenesis of the soluble alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA)-binding domain of glutamate receptor type D (GluR-D). Biochemical Society Transactions 25(3): 835-838, 1997

Potentiation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA)-selective glutamate receptor function by a nootropic drug, idebenone. Biological & Pharmaceutical Bulletin 17(1): 70-73, 1994

Oligomerization and ligand-binding properties of the ectodomain of the a-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor subunit GluRD. The Journal of Biological Chemistry 274(41): 937-43, 1999

Early continuous white noise exposure alters l-alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor subunit glutamate receptor 2 and gamma-aminobutyric acid type a receptor subunit beta3 protein expression in rat auditory cortex. Journal of Neuroscience Research 88(3): 614-619, 2010

A desensitization-inhibiting mutation in the glutamate binding site of rat alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor subunits is dominant in heteromultimeric complexes. Neuroscience Letters 277(3): 161-164, 1999

Oligomerization and ligand-binding properties of the ectodomain of the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor subunit GluRD. Journal of Biological Chemistry 274(41): 28937-28943, 1999